Selected Experience Related To Regulatory Matters
Macaluso LLP serves as fund formation counsel and as general counsel to the sponsor of a commodities-focused funds group.
FUNDS, SECURTIES OFFERINGS, REGULATORY, INTERNATIONAL, CAPITAL MARKETS
Macaluso LLP assisted a U.S.-based family office in the sale of its nanotech portfolio business located in international affiliates in Japan, Singapore, and Israel to a NASDAQ listed company.
M&A, TECHNOLOGY, INTERNATIONAL, COMMERCIALIZATION, SECURTIES OFFERINGS, ASIA, MIDDLE EAST, REGULATORY, CAPITAL MARKETS
Our Managing Partner acted as Treasury counsel with responsibility for all global treasury activities of a $120 billion subsidiary of a Fortune 25 company for over a dozen years with respect to virtually all of its capital markets and structured finance activities around the world. Part of the on-the-ground team that acquired the business that became the company’s London and ultimately European operations. Member of the leadership team that built and put into place the first funding facilities for the new European treasury group and set up its operations.
COUNSEL SERVICES, FINANCIAL SERVICES, TREASURY, U.S., EUROPE, SOUTH AMERICA, SECURITIES OFFERINGS, ABS, STRUCTURED FINANCE, INTERNATIONAL, REGULATORY, CAPITAL MARKETS
As counsel to issuers, sponsors, and commercial and investment banks, the issuance of asset-backed securities and other structured finance transactions across several dozen asset classes, through direct structures, private placements, 144A offerings, asset-backed commercial paper programs, structured investment vehicles and asset-backed shelves.
FINANCIAL SERVICES, BANKS, STRUCTURED FINANCE, ABS, REGULATORY, SECURITIES OFFERINGS, CAPITAL MARKETS
Counsel to a health care company in the growth stage currently rolling out its cardiovascular program in Asia. Working in five countries and ultimately rolling the program out in over 30 countries in the region. Set up U.S. and Hong Kong operations. Responsible for managing the local medical privacy, local FDA and regulatory approach. Working with partners and investors across U.S. and Asia. Also represent the company in its Middle East expansion beginning in the U.A.E.
HEALTHCARE, INTERNATIONAL, ASIA, MIDDLE EAST, REGULATORY, COMMERCIALIZATION, CAPITAL MARKETS
As counsel to domestic and global agribusiness conglomerates and middle-market companies, European and U.S. money center banks, and sector-focused funds, several billion dollars of transactions, projects and financings across the agriculture sector.
BANKS, FUNDS, PROJECT FINANCE, U.S., EUROPE, ASIA, AGRICULTURE, INTERNATIONAL, REGULATORY, SECURITIES OFFERINGS, CAPITAL MARKETS
Assisted leading medical research institution and related entities in connection with their efforts to commercialize intellectual properties.
HEALTHCARE, COMMERCIALIZATION, M&A, INTERNATIONAL, REGULATORY, SECURITIES OFFERINGS, TECHNOLOGY, U.S., SOCIAL IMPACT, CAPITAL MARKETS
As Senior Administrative Officer, Minnesota Department of Commerce, one of our lawyers directed healthcare reform efforts for the Governor’s Health Cabinet on methods to reduce annual state healthcare costs of $40 billion through administrative uniformity and simplification, attaining primary consensus among healthcare industry leaders (representing healthcare providers and payers) on standardized, electronic medical billing to reduce costs and end over 14 years of piecemeal agreement, resulting in an annual estimated reduction in costs of $56 million.
GOVERNMENT, REGULATORY, HEALTHCARE, TECHNOLOGY, U.S., CAPITAL MARKETS
Acted as adviser to principally U.S. private equity funds and investors making investments in Asia, including in or through China, Japan, Malaysia, Indonesia, Vietnam, Singapore and Hong Kong.
FUNDS, INTERNATIONAL, ASIA, M&A, REGULATORY, SECURITIES OFFERINGS, TECHNOLOGY, HEALTHCARE, AGRICULTURE, CAPITAL MARKETS
General Counsel for a company in the direct investment and asset management business with operations in U.S., Asia and Europe. Responsible for global legal strategy and execution for all domestic and international investments, transactions and operations of the firm, including regulatory matters. The firm owns and manages a portfolio of directly-held private investments in established and growth stage companies, which include leading domestic and international brands, companies and technologies primarily in sectors such as Healthcare, AgTech, FinTech and Sports & Entertainment. Developed the company’s risk management and portfolio intake and monitoring procedures.
COUNSEL SERVICES, HEALTHCARE, SPORTS & ENTERTAINMENT, FINANCIAL SERVICES, INTERNATIONAL, U.S., ASIA, EUROPE, MIDDLE EAST, AGRICULTURE, TECHNOLOGY, REGULATORY, CAPITAL MARKETS
On behalf of several prominent private investment funds, the design and formation of credit opportunity and private equity funds and the structuring and execution of various transactions to acquire, finance, and leverage fund assets on the one hand and to monetize or dispose of fund assets on the other hand.
FUNDS, M&A, INTERNATIONAL, SECURITIES OFFERINGS, REGULATORY, U.S., FINANCIAL SERVICES, CAPITAL MARKETS
Multibillion-dollar/euro government bailouts in the U.S. and Europe. Restructurings and workouts of financial institutions, funds, programs and complex instruments. Clients called on teams led by our Managing Partner from the inception of the capital markets crisis in July 2007. He assisted global banking institutions in the United States and Europe, issuers, sponsors of complex instruments and investment funds in maintaining, obtaining, and in some cases restructuring or otherwise working out privately and through government programs over $150 billion of liquidity.
FINANCIAL SERVICES, U.S., EUROPE, BANKS, STRUCTURED FINANCE, INTERNATIONAL, ABS, REGULATORY, CAPITAL MARKETS
Managed pre-listing and pre-sale process for high-growth companies in Asia through private equity rounds including in some cases a complete restructuring of the company.
FUNDS, ASIA, REGULATORY, SECURITIES OFFERINGS, CAPITAL MARKETS
Advisor on structuring and negotiating a €300 million portfolio of Italian mortgage assets using Malta SPV structure.
FINANCIAL SERVICES, STRUCTURED FINANCE, EUROPE, ABS, INTERNATIONAL, REGULATORY, CAPITAL MARKETS
Performed pre-IPO and/or pre-PE investment due diligence and managed pre-investment and later the pre-exit strategy relative to companies in various sectors in China including pharmaceutical companies, retailers, advanced robotics, printing, plastics and food and beverage companies.
FUNDS, M&A, HEALTHCARE, TECHNOLOGY, AGRICULTURE, INTERNATIONAL, REGULATORY, CAPITAL MARKETS
Lead counsel on behalf of the lead bank/arranger with regard to a single $9 billion structured loan involving four public companies including two of the world’s largest banks.
FINANCIAL SERVICES, BANKS, STRUCTURED FINANCE, ABS, REGULATORY, CAPITAL MARKETS
As attorney-adviser (international) with U.S. Department of Commerce in Washington, D.C., one of our lawyers advised client agencies within the International Trade Administration (ITA) on export promotion and U.S. government advocacy supporting the interests of U.S. companies. The attorney provided legal advice to assist U.S. companies with issues involving foreign trade compliance under applicable trade agreements (particularly WTO and NAFTA) and U.S. trade statutes including Sections 301 (U.S. trade retaliation) and 201 (safeguards) of the Trade Act of 1974 and Section 301 and Section 337 (intellectual property rights).
GOVERNMENT, INTERNATIONAL, TRADE, REGULATORY, CAPITAL MARKETS
Advised social impact private equity fund in structuring its investments and strategy for investments into China, Indonesia, and Vietnam and assessed its infra-structure for making investments generally.
FUNDS, SOCIAL IMPACT, ASIA, REGULATORY, CAPITAL MARKETS
Lead counsel for the arranger for a $10 billion multistrategy, multi-asset “club” conduit funding facility on behalf of the issuer and as lead counsel for the transaction divided into subfacilities, including a master trust and options for committed long-term conduit financing.
FINANCIAL SERVICES, STRUCTURED FINANCE, ABS, BANKS, REGULATORY, CAPITAL MARKETS
As counsel to the originator, the first-of-its-kind innovative $26 billion partial liquidity enhanced extendible notes and commercial paper program.
FINANCIAL SERVICES, STRUCTURED FINANCE, SECURITIES OFFERINGS, ABS, BANKS, REGULATORY, CAPITAL MARKETS